People
Ed Olhava
Ed Olhava is Versant Ventures’ current Scientist-in-Residence. Medicinal chemist with former IFM preclinical leadership and Epizyme/Millennium discovery roles, including co-invention of ixazomib. Stanford chemistry graduate with Harvard doctorate.
Roles
Versant Ventures
CurrentScientist-in-Residence